Roivant Sciences roivant.com


Public list: Unicorns - Billion Dollar Startups (363) Pharma Startups (6570) SoftBank Investments 2017-2019 (97)

Roivant Sciences focuses on developing and commercializing therapies through wholly- or majority-owned subsidiary companies including, Axovant, Myovant, Dermavant, Enzyvant, and Urovant.

Roivant Sciences focuses on developing and commercializing therapies through wholly- or majority-owned subsidiary companies including, Axovant, Myovant, Dermavant, Enzyvant, and Urovant.

Company (Alive / Active)

Phone:

Fax:

320 West 37th Street
6th Floor
New York, 10018
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Roivant Sciences $2300M Dec 31, 2019
Sumitomo Dainippon Pharma $0M May 16, 1949

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Roivant Sciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors